BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PBX1, P40424, 5087
557 results:

  • 1. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lupus susceptibility gene
    Choi SC; Park YP; Roach T; Jimenez D; Fisher A; Zadeh M; Ma L; Sobel ES; Ge Y; Mohamadzadeh M; Morel L
    Sci Adv; 2024 Mar; 10(13):eadi4310. PubMed ID: 38536923
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. pbx1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications.
    Kao TW; Chen HH; Lin J; Wang TL; Shen YA
    Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189085. PubMed ID: 38341110
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CircRNAome of Childhood Acute Lymphoblastic leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in
    Gutierrez-Camino A; Caron M; Richer C; Fuchs C; Illarregi U; Poncelet L; St-Onge P; Bataille AR; Tremblay-Dauphinais P; Lopez-Lopez E; Camos M; Ramirez-Orellana M; Astigarraga I; Lécuyer É; Bourque G; Martin-Guerrero I; Sinnett D
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338754
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Small nucleolar RNA Snora73 promotes psoriasis progression by sponging miR-3074-5p and regulating pbx1 expression.
    Zhang L; Guo H; Zhang X; Wang L; Wei F; Zhao Y; Wang B; Meng Y; Li Y
    Funct Integr Genomics; 2024 Jan; 24(1):15. PubMed ID: 38240925
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Regulation of the STAT3 pathway by lupus susceptibility gene pbx1 in T cells.
    Roach T; Park YP; Choi SC; Morel L
    Mol Immunol; 2024 Jan; 165():1-10. PubMed ID: 38056350
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy.
    Al Barashdi MAS; Ali A; McMullin MF; Mills K
    Ann Hematol; 2024 Jan; 103(1):73-88. PubMed ID: 37917373
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.
    Edwards CL; Engel JA; de Labastida Rivera F; Ng SS; Corvino D; Montes de Oca M; Frame TC; Chauhan SB; Singh SS; Kumar A; Wang Y; Na J; Mukhopadhyay P; Lee JS; Nylen S; Sundar S; Kumar R; Engwerda CR
    JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917177
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis.
    Meriç N; Albayrak E; Gülbaş Z; Kocabaş F
    Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/pbx1 Axis.
    Wang QM; Lian GY; Sheng SM; Xu J; Ye LL; Min C; Guo SF
    Mol Cancer Res; 2024 Feb; 22(2):125-136. PubMed ID: 37889101
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
    Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
    Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
    Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular characterization of TCF3::pbx1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment.
    Burmeister T; Gröger D; Gökbuget N; Spriewald B; Starck M; Elmaagacli A; Hoelzer D; Keller U; Schwartz S
    Sci Rep; 2023 Sep; 13(1):15167. PubMed ID: 37704696
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mesenchymal stem cells overexpressing pbx1 alleviates haemorrhagic shock-induced kidney damage by inhibiting NF-κB activation.
    Jia D; Han J; Cai J; Huan Z; Wang Y; Ge X
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119571. PubMed ID: 37673222
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.
    Ma L; Wang J; Yang Y; Lu J; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Zhang Y; Sang X; Lu L; Wan X; Zhang K; Chen Y; Yu J; Zhuo R; Wu S; Pan J; Zhou X; Hu Y; Hu S
    Hematology; 2023 Dec; 28(1):2247253. PubMed ID: 37594294
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [leukemia Genotype Analysis of Children with Acute Lymphoblastic leukemia in Yunnan Area].
    Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Establishment of the lymphoid ETS-code reveals deregulated ETS genes in Hodgkin lymphoma.
    Nagel S; Meyer C; Pommerenke C
    PLoS One; 2023; 18(7):e0288031. PubMed ID: 37428779
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
    Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
    Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.